Prevalence of cocaine consumption in pregnant women and its incidence with eclampsia

Currently, we are witnessing a notable growth in the availability of a wide range of psychoactive substances, a situation that is aggravated by easy accessibility and a social and economic environment that, in many cases, favors their consumption. This phenomenon has led to a worrying increase in the number of pregnant women turning to drug use, with cocaine being one of the most prevalent substances, and has contributed significantly to a public health crisis, affecting not only pregnant women. of pregnancy, but also to future babies. This increase in cocaine consumption during pregnancy poses risks for both fetal development and complications for the mother. Systematic review of studies found in databases, published in the last 4 years (2020), which are available in full text and in which cocaine use and pregnancy are related. Cocaine has a prevalence of 31% among pregnant women. The effects of cocaine use in pregnancy include reduced uterine blood flow and placental vasoconstriction, resulting in significant obstetric complications, such as IUGR (19.5%), PD (18.7%), PPROM (18.6%), Miscarriages (13.3%), PB (9.8%), Postpartum hemorrhage (2.11%), Preeclampsia and eclampsia (5.4% and 2.8%). Furthermore, they were observed, sexually transmitted infections, psychiatric disorders and respiratory conditions, among others. The importance of promoting an inclusive approach that eliminates the stigmatization of women who consume illicit drugs is reinforced, promoting adequate prenatal care, both physical and mental, to minimize the harm caused by consumption.